These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4008772)

  • 41. Changes in ventricular refractoriness after an extrastimulus: effects of prematurity, cycle length and procainamide.
    Cain ME; Martin TC; Marchlinski FE; Josephson ME
    Am J Cardiol; 1983 Nov; 52(8):996-1001. PubMed ID: 6637852
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of lidocaine on regional intraventricular conduction in patients with coronary artery disease.
    Wiener I; Mindich B; Kupersmith J
    Am Heart J; 1981 Jul; 102(1):53-8. PubMed ID: 7246413
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Electrophysiologic effects of chronic amiodarone therapy in patients with ventricular arrhythmias.
    Finerman WB; Hamer A; Peter T; Weiss D; Mandel WJ
    Am Heart J; 1982 Nov; 104(5 Pt 1):987-96. PubMed ID: 7137016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Electrophysiological study of intravenous amiodarone in dogs.
    Ferrero JA; Insa LD; Ruiz-Ros V; Chorro J; Esplugues J; López-Merino V
    Arch Farmacol Toxicol; 1981 Aug; 7(2):239-48. PubMed ID: 7332365
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmacokinetics and pharmacodynamics of intravenous agents for ventricular arrhythmias.
    Nolan PE
    Pharmacotherapy; 1997; 17(2 Pt 2):65S-75S; discussion 89S-91S. PubMed ID: 9085342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of procainamide's effect on cardiac conduction in dogs by extracellular potassium concentration. A quantitative analysis.
    Villemaire C; Nattel S
    Circulation; 1994 Jun; 89(6):2870-8. PubMed ID: 8205703
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rate-dependent effects of lidocaine on His-Purkinje conduction in the intact neonatal heart--characterization and amplification by N-acetylprocainamide.
    Dise TL; Stolfi A; Clarkson CW; Pickoff AS
    J Pharmacol Exp Ther; 1991 Nov; 259(2):535-42. PubMed ID: 1719192
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical efficacy and electropharmacology of continuous intravenous amiodarone infusion and chronic oral amiodarone in refractory ventricular tachycardia.
    Saksena S; Rothbart ST; Shah Y; Cappello G
    Am J Cardiol; 1984 Aug; 54(3):347-52. PubMed ID: 6465016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of amiodarone on refractory ventricular fibrillation in acute myocardial infarction: experimental study.
    Anastasiou-Nana MI; Nanas JN; Nanas SN; Rapti A; Poyadjis A; Stathaki S; Moulopoulos SD
    J Am Coll Cardiol; 1994 Jan; 23(1):253-8. PubMed ID: 8277089
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of oral amiodarone on rate-dependent changes in refractoriness in patients with Wolff-Parkinson-White syndrome.
    Brugada P; Wellens HJ
    Am J Cardiol; 1985 Nov; 56(13):863-6. PubMed ID: 4061328
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use-dependent prolongation of ventricular tachycardia cycle length by type I antiarrhythmic drugs in humans.
    Kidwell GA; Greenspon AJ; Greenberg RM; Volosin KJ
    Circulation; 1993 Jan; 87(1):118-25. PubMed ID: 8418998
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction.
    Feld GK; Venkatesh N; Singh BN
    Circulation; 1986 Jul; 74(1):197-204. PubMed ID: 3708774
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The human atrial strength-interval relation. Influence of cycle length and procainamide.
    Buxton AE; Marchlinski FE; Miller JM; Morrison DF; Frame LH; Josephson ME
    Circulation; 1989 Feb; 79(2):271-80. PubMed ID: 2914346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Termination of ventricular tachycardia: role of tachycardia cycle length.
    Roy D; Waxman HL; Buxton AE; Marchlinski FE; Cain ME; Gardner MJ; Josephson ME
    Am J Cardiol; 1982 Dec; 50(6):1346-50. PubMed ID: 7148712
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Electrophysiologic study of antiarrhythmic agents in man].
    Puech P
    Arch Inst Cardiol Mex; 1977; 47(2):233-47. PubMed ID: 901058
    [No Abstract]   [Full Text] [Related]  

  • 56. Cycle-length response of ventricular tachycardia associated with coronary artery disease to procainamide and amiodarone.
    Vaitkus PT; Buxton AE; Josephson ME; Marchlinski FE
    Am J Cardiol; 1990 Sep; 66(7):710-4. PubMed ID: 2399887
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A quantitative analysis of use-dependent ventricular conduction slowing by procainamide in anesthetized dogs.
    Villemaire C; Savard P; Talajic M; Nattel S
    Circulation; 1992 Jun; 85(6):2255-66. PubMed ID: 1317275
    [TBL] [Abstract][Full Text] [Related]  

  • 58. T wave changes persisting after ventricular pacing in canine heart are altered by 4-aminopyridine but not by lidocaine. Implications with respect to phenomenon of cardiac 'memory'.
    del Balzo U; Rosen MR
    Circulation; 1992 Apr; 85(4):1464-72. PubMed ID: 1555287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Frequency-dependent effects of quinidine on the ventricular action potential and QRS duration in humans.
    Nademanee K; Stevenson WG; Weiss JN; Frame VB; Antimisiaris MG; Suithichaiyakul T; Pruitt CM
    Circulation; 1990 Mar; 81(3):790-6. PubMed ID: 2306831
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of amiodarone, sematilide, and sotalol on QT dispersion.
    Cui G; Sen L; Sager P; Uppal P; Singh BN
    Am J Cardiol; 1994 Nov; 74(9):896-900. PubMed ID: 7526675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.